Hydrogen sulfide is involved in dexamethasone-induced hypertension in rat

Pimenta, 2012, Adverse cardiovascular outcomes of corticosteroid excess, Endocrinology, 153, 5137, 10.1210/en.2012-1573 Baid, 2004, Glucocorticoid excess and hypertension, Curr. Hypertens. Rep, 6, 493, 10.1007/s11906-004-0046-0 Kalimi, 1989, Role of antiglucocorticoid RU 486 on dexamethasone-induced hypertension in rats, Am. J. Physiol, 256, E682 De Watcher, 2003, Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide, Eur. J. Pediat, 162, 488, 10.1007/s00431-003-1233-8 Nieman, 1985, Loriaux, Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486, J. Clin. Endocrinol. Metab, 61, 536, 10.1210/jcem-61-3-536 Ullian, 1999, The role of corticosteroids in the regulation of vascular tone, Cardiovasc. Res, 41, 55, 10.1016/S0008-6363(98)00230-2 Kurland, 1951, The potentiating effect of ACTH and of cortisone of pressor response to intravenous infusion of L-nor-epinephrine, Proc. Soc. Exp. Biol. Med, 78, 28, 10.3181/00379727-78-18962 Berecek, 1978, Whole body vascular reactivity during the development of deoxycorticosterone acetate hypertension in the pig, Circ. Res, 42, 764, 10.1161/01.RES.42.6.764 Kornel, 1995, Study on the mechanisms of glucocorticoid-induced hypertension: glucocorticoids increase transmembrane Ca2+ influx in vascular smooth muscle in vivo, Endocr. Res, 21, 203, 10.3109/07435809509030436 Provencher, 1995, Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells, J. Steroid Biochem. Mol. Biol, 52, 219, 10.1016/0960-0760(94)00168-L Kornel, 1993, The role of vascular steroid receptors in the control of vascular contractility and peripheral vascular resistance, J. Steroid Biochem. Mol. Biol, 45, 195, 10.1016/0960-0760(93)90142-J Wallerath, 1999, Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension, Proc. Natl. Acad. Sci. U.S.A., 96, 13357, 10.1073/pnas.96.23.13357 Ray, 1997, Glucocorticoid inhibition of cytokine-induced E-selectin promoter activation, Biochem. Soc. Trans, 25, 189S, 10.1042/bst025189s Goodwin, 2008, A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension, J. Am. Soc. Nephrol, 19, 1291, 10.1681/ASN.2007080911 Goodwin, 2011, Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension, J. Hypertens, 29, 1347, 10.1097/HJH.0b013e328347da54 Goodwin, 2012, Glucocorticoid-induced hypertension, Pediatr. Nephrol, 27, 1059, 10.1007/s00467-011-1928-4 Ong, 2011, How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids, Endocrinol. Metab. Clin. North Am, 40, 393, 10.1016/j.ecl.2011.01.010 Waldron, 1994, Contribution of both nitric oxide and a change in membrane potential to acetylcholine-induced relaxation in the rat small mesenteric artery, Br. J. Pharmacol, 112, 831, 10.1111/j.1476-5381.1994.tb13154.x Edwards, 2010, Endothelium-derived hyperpolarising factors and associated pathways: a synopsis, Pflugers Arch, 459, 863, 10.1007/s00424-010-0817-1 McGuire, 2001, Endothelium-derived relaxing factors: a focus on endothelium-derived hyperpolarizing factor(s), Can. J. Physiol. Pharmacol, 79, 443, 10.1139/y01-025 Ellis, 2003, Endothelium-derived reactive oxygen species: their relationship to endothelium-dependent hyperpolarization and vascular tone, Can. J. Physiol. Pharmacol, 81, 1013, 10.1139/y03-106 Sandow, 2007, C-type natriuretic peptide: a new endothelium-derived hyperpolarizing factor?, Trends Pharmacol. Sci, 28, 61, 10.1016/j.tips.2006.12.007 Tang, 2013, H2S is an endothelium-derived hyperpolarizing factor, Antioxid. Redox Signal, 19, 1634, 10.1089/ars.2012.4805 Wang, 2002, Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?, FASEB J., 16, 1792, 10.1096/fj.02-0211hyp Wang, 2003, The gasotransmitter role of hydrogen sulfide, Antioxid. Redox Signal, 5, 493, 10.1089/152308603768295249 Zhu, 2010, Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide-treated macrophages, Cell. Mol. Life Sci, 67, 1119, 10.1007/s00018-009-0250-9 Li, 2009, Dexamethasone inhibits lipopolysaccharide-induced hydrogen sulphide biosynthesis in intact cells and in an animal model of endotoxic shock, J. Cell. Mol. Med, 13, 2684, 10.1111/j.1582-4934.2008.00610.x Shafagoj, 1992, Dehydroepiandrosterone prevents dexamethasone-induced hypertension in rats, Am. J. Physiol, 263, E210 Iacono, 2009, Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney, Am. J. Hypertens, 22, 777, 10.1038/ajh.2009.68 d'Emmanuele di Villa Bianca, 2011, Hydrogen sulfide-induced dual vascular effect involves arachidonic acid cascade in rat mesenteric arterial bed, J. Pharmacol. Exp. Ther, 337, 59, 10.1124/jpet.110.176016 Lippolis, 2003, Time course of vascular reactivity to contracting and relaxing agents after endothelial denudation by balloon angioplasty in rat carotid artery, Atherosclerosis, 171, 171, 10.1016/j.atherosclerosis.2003.07.012 d'Emmanuele di Villa Bianca, 2010, Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2, Br. J. Pharmacol, 161, 1835, 10.1111/j.1476-5381.2010.01016.x Fusco, 2012, Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors, Eur. Urol, 62, 1174, 10.1016/j.eururo.2012.07.025 d'Emmanuele di Villa Bianca, 2013, Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia, Proc. Natl. Acad. Sci. U.S.A., 110, 15812, 10.1073/pnas.1309049110 Whitworth, 1989, The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume, J. Hypertens, 7, 537, 10.1097/00004872-198907000-00005 Whitworth, 1990, A ‘hypertensinogenic’ class of steroid hormone activity in man?, Clin. Exp. Pharmacol. Physiol, 17, 163, 10.1111/j.1440-1681.1990.tb01299.x Saruta, 1996, Mechanism of glucocorticoid-induced hypertension, Hypertens. Res, 19, 1, 10.1291/hypres.19.1 Whitworth, 1997, Glucocorticoids and hypertension in man, Clin. Exp. Hypertens, 19, 871, 10.3109/10641969709083192 Christensen, 1993, Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats, J. Vasc. Res, 30, 73, 10.1159/000158978 Yamanaka, 1998, Characterization of endothelium-dependent relaxation independent of NO and prostaglandins in guinea pig coronary artery, J. Pharmacol. Exp. Ther, 285, 480 Félétou, 2009, EDHF: an update, Clin. Sci, 117, 139, 10.1042/CS20090096 Lynn, 2011, Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential, Exp. Rev. Clin. Pharm, 4, 97, 10.1586/ecp.10.130 Yang, 2008, H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase, Science, 322, 587, 10.1126/science.1162667 Yan, 2004, Changes of endogenous hydrogen sulfide (H2S) in hypertensive rats, Zhonghua Er Ke Za Zhi, 42, 172